| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc | Director | Share Option (right to buy) | 48K | Jun 25, 2024 | Direct | ||
| Epizyme, Inc. | Director | Common Stock, par value $0.0001 | 0 | $1.41 | Aug 12, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | Jun 25, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
| CNTA | Centessa Pharmaceuticals plc | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| EPZM | Epizyme, Inc. | Aug 12, 2022 | 1 | $0 | 4 | Aug 16, 2022 | Director |
| CNTA | Centessa Pharmaceuticals plc | Jun 30, 2022 | 1 | $0 | 4 | Jul 5, 2022 | Director |
| EPZM | Epizyme, Inc. | May 17, 2022 | 2 | $0 | 4 | May 19, 2022 | Director |
| EPZM | Epizyme, Inc. | Nov 16, 2021 | 2 | $0 | 4 | Nov 18, 2021 | Director |
| EPZM | Epizyme, Inc. | Nov 16, 2021 | 0 | $0 | 3 | Nov 18, 2021 | Director |
| CNTA | Centessa Pharmaceuticals plc | May 27, 2021 | 0 | $0 | 3 | May 27, 2021 | Director |